Keytruda (pembrolizumab) is a prescription drug that’s used to treat certain forms of cancer. Keytruda comes as an intravenous (IV) infusion (an injection into your vein given over time).
Results from the study, which focused on gynecological malignant tumors, were presented at the Society for Immunotherapy of ...
While some of the initial excitement around immunotherapies has waned, companies—particularly smaller biotechs—are developing ...
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...
M uch to the chagrin of investors looking to get rich quickly with a biopharma investment, the drug development cycle is, by ...
Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...
Natalie Willacy has so far poured $40,000 of her super into self-funding her own immunotherapy treatment with the ...
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business. But Merck's vaccine that prevents cancer from HPV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback